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used as a bridge to surgery?”  [1–5] . It is clear that 8 years 
ago, the use of a stent preoperatively was considered the 
standard of care and highly recommended in every ter-
tiary center  [6, 7] . Furthermore, the use of a stent as a de-
finitive palliative treatment for the remaining life of a pa-
tient was still a matter of debate.
 However, today, in December 2016, everything is re-
versed. In 2014, the European Society of Gastrointestinal 
Endoscopy (ESGE) presented guidelines for the use of 
metallic stents in obstructive colorectal cancer  [8] . The 
special focus is on 2 items: (a) SEMS placement as a bridge 
to elective surgery is not recommended as a standard 
treatment of symptomatic left-sided malignant colonic 
obstruction. For patients with potentially curable but ob-
structing left-sided colonic cancer, stent placement may 
be considered as an alternative to emergency surgery in 
those who have an increased risk of postoperative mortal-
ity, i.e., American Society of Anesthesiologists (ASA) 
physical status  ≥ III and/or age >70 years. In addition, to 
create the perfect scenario for a huge debate, the so-called 
poor son returned in glory: (b) SEMS placement is recom-
mended as the preferred treatment for palliation of ma-
lignant colonic obstruction, except in patients treated or 
considered for treatment with antiangiogenic drugs (e.g., 
bevacizumab). How did we arrive at this conclusion?
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 Life, like scientific knowledge, is most of the time a 
rollercoaster, meaning that a subject can go up and down 
in the course of time. This is also true with respect to the 
application of a self-expandable metallic stent (SEMS) as 
a definitive palliative treatment in obstructive colorectal 
cancer. In the last years of the first decade of the 21 st cen-
tury, papers concerning SEMS, as a nonsurgical palliative 
treatment for malignant colorectal obstruction, always 
asked the same question in the introduction: “the ques-
tion remains: are SEMS used for definitive palliation of 
malignant colorectal obstruction as successful as those 
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 Colorectal cancer is one of the leading malignancies 
worldwide  [4, 9] . One of the most common complica-
tions is obstruction, which can occur in up to 20% of the 
patients  [4, 7] . The majority of patients presenting with 
obstruction have advanced disease, are often elderly indi-
viduals, and have overall a poor medical condition  [4, 7, 
10, 11] . Curative treatment is not feasible, and therefore 
palliation is the primary aim in these patients  [1, 4, 10, 
12] . Emergency surgery in patients with an unprepared 
colon leads to significant morbidity and mortality  [4, 13, 
14] . Furthermore, surgery often involves creation of a co-
lostomy, which is not reversed in up to 50% of the pa-
tients, leading to a profound negative impact on the qual-
ity of life  [1, 4, 13, 14] . 
 In 1990, an unknown Berlin surgeon used a metallic 
stent to treat a patient with obstructive rectal cancer, and 
without foreseeing the future, he initiated an endless de-
bate  [15] . Two recent meta-analyses have created a robust 
case for SEMS in the palliative scenario  [16, 17] : (1) Liang 
et al.  [16] conducted a meta-analysis of 9 studies (3 ran-
domized controlled trials as well as 2 prospective and 4 
retrospective trials) comparing SEMS to surgery for pal-
liative treatment of colorectal obstruction. A combined 
analysis revealed that the SEMS group had similar short-
term complication and mortality risks as the surgical 
group. However, the SEMS group was associated with a 
shorter hospitalization time followed by a quick recovery. 
(2) Zhao et al.  [17] conducted a new meta-analysis con-
cerning 13 relevant articles (prospective, retrospective, 
and controlled), representing 837 patients (SEMS group, 
 n = 404; surgery group,  n = 433). The authors found that 
compared to the surgery group, the SEMS group showed 
lower clinical success but shorter durations of hospital 
stay, shorter time to initiation of chemotherapy, and a 
lower rate of stoma formation. Both meta-analyses re-
ported a successful relief of obstruction when palliative 
SEMS placement was concerned (with a >90% rate). Ad-
ditionally, the SEMS group experienced a significantly 
lower rate of 30-day mortality. Finally, the rate of total 
complications was similar between these 2 groups. Short-
term complications occurred more often in the palliative 
surgery group, while late complications were more fre-
quent in the SEMS group. Stent-related complications 
(34%) mainly included colonic perforation (10%), stent 
migration (9%), and reobstruction (18%), far from the 
disastrous numbers that some papers reported in the past; 
the results were questioned due to the poor experience of 
the endoscopists included in the studies  [11, 18] . A recent 
large prospective study prospectively followed 255 pa-
tients submitted to SEMS placement in the palliative set-
ting. After 1 year of follow-up, clinical success was ob-
tained in 96% of the patients still alive and reporting a rate 
of complications of 36.8%, namely a perforation rate of 
5.1%  [19] . In previous retrospective series, we observed 
that sustained relief of obstruction without reinterven-
tion was obtained in approximately 75% of the patients 
until death, and this result could be further enlarged to 
80–90% of the cases using a second stent  [2, 4, 12] . Fur-
thermore, other recent studies suggested that placing a 
second stent in patients previously submitted to palliative 
stenting was a viable option  [20, 21] .
 One important issue in delivering SEMS in the pallia-
tive scenario is the evaluation of risk factors for complica-
tions. In a large retrospective series, Small et al.  [12]  iden-
tified complete obstruction, operator experience (<20 
procedures), stricture dilatation, stent diameter  ≤ 22 mm, 
and bevacizumab as predictors of complications. In a ret-
rospective series of 39 patients, Jung et al.  [2]  found that 
the location of the obstruction and the length of the stent 
were significant factors associated with a good outcome. 
Shorter stents (<10 cm) had better outcomes than longer 
stents ( ≥ 10 cm), and patients with a distal colorectal ob-
struction had better outcomes than those with a proximal 
colorectal obstruction. Interestingly, some authors affirm 
that when the placement of a stent in the proximal colon 
(i.e., proximal to the splenic flexure) is compared to a 
stent placed in the left colon, there were no differences in 
the technical and clinical success rates for both proce-
dures, suggesting that the through-the-scope technique 
makes all tumor locations accessible from a technical per-
spective  [4, 12, 22] .
 Another study retrospectively analyzed 201 consecu-
tive patients undergoing stenting for incurable malignant 
obstruction  [3] . Extrinsic and long colorectal stenoses 
were associated with higher rates of technical and clinical 
failures, migration was associated with a stent diameter 
<25 mm, and bevacizumab therapy increased the risk of 
perforation by 19.6-fold. Concerning factors associated 
with survival, a Karnofsky performance status of  ≤ 50 was 
associated with shorter survival and a 3.7-fold higher risk 
of death within 6 months after the stent was placed. One 
important issue is the success of stenting extrinsic malig-
nant stenosis. The technical and clinical success rates of 
placing SEMS in extracolonic malignancies have been re-
ported to range from 67 to 96% and from 20 to 96%, re-
spectively  [23–27] , which are poor results when com-
pared to those reported for stenting of colorectal cancer 
 [28, 29] . One retrospective study comparing SEMS place-
ment for primary colonic tumor versus extracolonic ma-
lignancies reported an increased complication rate in the 
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extracolonic malignancy group (33 vs. 9%)  [27] . How-
ever, other studies did not report extrinsic obstruction as 
a risk factor for complications  [28, 29] . The recent ESGE 
guidelines suggest that it is generally advisable to attempt 
palliative stenting of extracolonic malignancies in order 
to avoid surgery in these patients who have a relatively 
short survival  [8] .
 In this issue of the  GE Portuguese Journal of Gastroen-
terology , Sousa et al.  [30] retrospectively analyzed 45 pa-
tients submitted to SEMS for palliation of obstructing 
malignant colorectal cancer over a 10-year period. As ex-
pected, experienced endoscopists (>20 procedures) re-
ported a technical and clinical success rate of >90%. Ad-
ditionally, relief of obstruction without intervention was 
maintained until death in 77.8% of the patients, and this 
rate was improved with reintervention, namely placing 
another stent in obstructed patients previously submitted 
to palliative stenting. In line with the literature, they re-
ported a 17.8% rate of complications including a 8.9% 
rate of perforations. The authors also analyzed possible 
predictors of complications, namely gender, age, location 
of tumor, presence of metastasis, and the Eastern Coop-
erative Oncology Group (ECOG) stage, which were not 
statistically significant predictors of complications. This 
is no surprise, as most of these factors have not emerged 
in the literature as predictors of complications, except the 
location of the tumor, namely a proximal location, which 
is a conflicting predictive factor as discussed before. How-
ever, in the study by Sousa et al.  [30] only 4 patients had 
their strictures located in the proximal colon, and there-
fore, it was impossible to draw conclusions from this low 
number of patients. Interestingly, the above-mentioned 
study identified the length of stenosis as an independent 
predictor of complications. This has been previously de-
bated in several studies with conflicting results: (1) 3 stud-
ies reported that stenting of a long obstructed segment 
was not associated with clinical failures  [31–33] ; (2) how-
ever, in 2 retrospective studies, a better outcome was ob-
served in short colon strictures  [2, 3] . One of these retro-
spective studies reported more technical failures in stric-
tures >4 cm (OR 5.33) and even clinical failures (OR 2.40) 
 [3] .
 Taken together and in conclusion, the study by Sousa 
et al.  [30] shows what experienced endoscopists have 
learned in the last 15 years, without the need of illuminat-
ing guidelines which have a lot of weak points and should 
be reopened for discussion. Definitive palliation of malig-
nant large bowel obstruction using metallic stents is as-
sociated with clinical success (including restenting) until 
death in 80–90% of the patients; it avoids colostomies and 
improves quality of life. The procedure provides rapid 
and effective relief of obstruction and is associated with 
acceptable morbidity and need for reintervention, as well 
as minimal mortality. It should be performed by experi-
enced endoscopists. Even in clinical situations with 
known risk factors (e.g., extrinsic, long, and total obstruc-
tions), stenting is an acceptable first option. So, in conclu-
sion, for palliation of malignant large bowel obstruction 
the answer is: stents for all.
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